You can buy or sell Agios and other stocks, options, ETFs, and crypto commission-free!
Agios Pharmaceuticals, Inc. Common Stock, also called Agios, is a biopharmaceutical company, which engages in the discovery and development of novel investigational medicines to treat cancer and rare genetic diseases. Read More It focuses on diseases that are directly caused by changes in genes or chromosomes, often passed from one generation to the next. The company was founded by Lewis Clayton Cantley, Tak W. Mak, Craig B. Thompson and Shin-Shan Michael Su on August 7, 2007 and is headquartered in Cambridge, MA.
52 Week High
52 Week Low
— per share
Expected Apr 30, Pre-Market